MedPath

Randomised controlled feasibility trial of a web-based alcohol treatment programme

Completed
Conditions
Hazardous or harmful alcohol use
Mental and Behavioural Disorders
Registration Number
ISRCTN31789096
Lead Sponsor
niversity College London (UCL)/Royal Free London NHS Foundation Trust (UK)
Brief Summary

2015 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/27965806/ 2017 results and process evaluation in: https://www.ncbi.nlm.nih.gov/pubmed/28879021 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29946479

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Participants will be hazardous and harmful drinkers in north London, identified using a validated screening tool such as AUDIT, referred from primary care, secondary care, or self-referred, to CAS.
2. Patients aged 18 or over at time of screening
3. Diagnosis of an alcohol use disorder using AUDIT criteria (score 8 or over)
4. Residing in a stable place of residence
5. Providing informed consent for randomisation, treatment and follow-up
6. Patients without prior internet experience, or without home access to the internet will be included, but will be offered additional training as part of their facilitated access to DYD.
All participants will be given information about local free or low-cost public internet access points, such as libraries, health centres and cluster rooms.

Exclusion Criteria

1. Patients undergoing treatment for substance use or primary drug dependence (excluding nicotine) in the past 90 days
2. Already receiving help for an alcohol use disorder
3. Outstanding legal issues likely to lead to imprisonment
4. Severe mental or physical illness likely to preclude active participation in treatment or follow-up
5. Severe physical dependency on alcohol (LDQ > 20)
6. Unable to consult in English without an interpreter
7. Pregnancy
8. Patients with severe physical dependency or severe and complex co-existing physical or mental health problems will be referred for Tier 4 services in line with DH guidelines
9. Patients at risk of high risk of self-harm or suicide will not be excluded, but will be referred back to their GP for additional help

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath